PMID: 9194019May 1, 1997Paper

Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory

Journal of Psychosomatic Research
Dónal G FortuneC E Griffiths

Abstract

The purpose of the present study was to undertake a clinical and psychometric reappraisal of the Psoriasis Life Stress Inventory (PLSI). Total PLSI score was inversely related to age of onset of psoriasis, but bore no significant relationship to duration or to clinical severity. Similarly, patients' stress score did not differ with regards to the nature of their current treatment, to their beliefs as to what was responsible for exacerbation or improvement of their condition, or to the patients' gender. Factor analysis extracted two factors which suggested that the psychosocial impact of psoriasis results from stress associated with: (i) engaging in anticipatory/avoidance coping behavior that is effected to limit the sociocognitive intrusiveness of psoriasis; and (ii) stress resulting from patients' beliefs or actual experiences of being evaluated by others solely on the basis of their skin. The internal reliability of the scale can be improved by the deletion of three items. Revision of the PLSI is recommended to render it psychometrically and clinically acceptable for use in the UK.

References

Jul 1, 1975·The British Journal of Dermatology·R B Coles, T J Ryan
Jan 1, 1978·Dermatologica·T Fredriksson, U Pettersson
Jan 1, 1992·Psychosomatics·D G Folks, F C Kinney
Jan 1, 1991·Journal of Psychosomatic Research·S WarrenR Cockerill
Jan 1, 1989·Journal of the American Academy of Dermatology·I H Ginsburg, B G Link
Jan 1, 1987·Behaviour Research and Therapy·J A TurnerP P Vitaliano
Feb 1, 1988·The British Journal of Dermatology·B Ramsay, M O'Reagan
Jan 1, 1987·Journal of Human Stress·G M ManuelB A Brantley
Jul 1, 1987·Journal of the American Academy of Dermatology·L GastonJ C Crombez
Jan 1, 1974·Dermatologica·E M Farber, M L Nall
Jun 1, 1971·Archives of Dermatology·R Baughman, R Sobel
Sep 1, 1968·Archives of Dermatology·E M FarberM L Nall
Jan 1, 1984·Social Science & Medicine·B J FeltonG A Hinrichsen
Feb 1, 1994·The British Journal of Dermatology·M S Al'AbadieD J Gawkrodger
Jan 1, 1993·Psychotherapy and Psychosomatics·I T HarvimaM Horsmanheimo
Mar 1, 1993·International Journal of Dermatology·M A GuptaC N Ellis

❮ Previous
Next ❯

Citations

Nov 7, 2009·Archives of Dermatological Research·Hanan MorsyGregor B E Jemec
May 28, 2009·Current Psychiatry Reports·Joseph A Locala
Mar 22, 2001·Journal of Psychosomatic Research·H L RichardsC J Main
Mar 22, 2000·Journal of the American Academy of Dermatology·R S HotardA B Fleischer
Dec 25, 2003·Psychological Assessment·Ulrich StangierUwe Gieler
May 16, 2000·The British Journal of Dermatology·M ScharlooH G Rooijmans
Jun 20, 2002·Clinical and Experimental Dermatology·D G FortuneC E M Griffiths
Jan 6, 1999·Journal of Clinical Pharmacy and Therapeutics·D M AshcroftC E Griffiths
Dec 24, 2009·Psychosomatic Medicine·Robert AderDavid Fiorentino
Feb 15, 2005·Annals of the Rheumatic Diseases·R G B LangleyC E M Griffiths
Mar 24, 2005·Dermatology : International Journal for Clinical and Investigative Dermatology·Jochen Schmitt, Gottfried Wozel
Feb 18, 2006·Dermatology : International Journal for Clinical and Investigative Dermatology·Maria EspositoSergio Chimenti
Oct 4, 2007·Dermatology : International Journal for Clinical and Investigative Dermatology·F SampognaUNKNOWN Italian Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) study group
Jun 26, 2001·Clinical and Experimental Dermatology·C E Griffiths, H L Richards
Sep 19, 2001·The Journal of Dermatology·S K MattooR Malhotra
Apr 17, 2004·The Journal of Investigative Dermatology·Francesca SampognaUNKNOWN IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) Investigators
Jun 12, 2004·The Journal of Investigative Dermatology·Helen L RichardsChristopher E M Griffiths
Aug 2, 2003·The British Journal of Dermatology·H L RichardsC E M Griffiths
Apr 26, 2006·The British Journal of Dermatology·F SampognaUNKNOWN IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) investigators
Jan 26, 2006·The British Journal of Dermatology·F SampognaUNKNOWN Italian Multipurpose Psoriasis Research on Vital Experiences (Improve) Study Group
Sep 27, 2007·Journal of the European Academy of Dermatology and Venereology : JEADV·A FinziUNKNOWN PSYCHAE Study Group
Aug 15, 1998·Journal of the American Academy of Dermatology·D G FortuneC E Griffiths
Dec 21, 2004·The British Journal of Dermatology·D G FortuneC E M Griffiths
Nov 26, 2005·The British Journal of Dermatology·H L RichardsC E M Griffiths
Jun 28, 2011·International Journal of Dermatology·Kabbur H BasavarajRamesh Rashmi
Dec 14, 2005·American Journal of Clinical Dermatology·Alexa B KimballYing Wu
Sep 11, 2012·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Muneeza RizwanLesley Elizabeth Rhodes
Sep 13, 2018·Journal of Clinical Psychology in Medical Settings·Ourania FountaDavid Hevey
Feb 5, 2011·Journal of Cutaneous Medicine and Surgery·Slavenka JankovicNadja Vasiljevic
May 8, 2018·International Journal of Dermatology·Laurie Rousset, Bruno Halioua
Oct 18, 2020·Dermatologic Therapy·Elif Burcu Yavuz DagliogluMustafa Aksoy
Feb 29, 2020·The British Journal of Dermatology·L AukerH S Young
Aug 20, 2021·Journal of Taibah University Medical Sciences·Raishan S BakarYeoh C Aun

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.